Cargando…
Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a
Gastric cancer is the fourth most common cancer worldwide, with a low 5-year survival rate. Epigenetic modification plays pivotal roles in gastric cancer development. However, the role of histone-modifying enzymes in gastric cancer remains largely unknown. Here we report that Sirt7, a NAD(+)-depende...
Autores principales: | Zhang, Shun, Chen, Ping, Huang, Zuoan, Hu, Xiaorong, Chen, Mengting, Hu, Shanshan, Hu, Yixin, Cai, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392652/ https://www.ncbi.nlm.nih.gov/pubmed/25860861 http://dx.doi.org/10.1038/srep09787 |
Ejemplares similares
-
Retraction Note: Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a
por: Zhang, Shun, et al.
Publicado: (2023) -
Danlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis
por: Chen, Rui, et al.
Publicado: (2023) -
miR-22 inhibits mouse ovarian granulosa cell apoptosis by targeting SIRT1
por: Xiong, Fang, et al.
Publicado: (2016) -
Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness
por: Ma, Wei, et al.
Publicado: (2015) -
0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop
por: Xia, Caixia, et al.
Publicado: (2017)